Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Koichi, Hirakawa"'
Autor:
Kentaro Mizuhara, Tsutomu Kobayashi, Mitsushige Nakao, Ryoichi Takahashi, Hiroto Kaneko, Kazuho Shimura, Koichi Hirakawa, Nobuhiko Uoshima, Katsuya Wada, Eri Kawata, Reiko Isa, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Akiko Yoneda, Akihide Watanabe, Chie Sotozono, Junya Kuroda
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3134-3144 (2023)
Abstract Background Primary ocular adnexal mucosa‐associated lymphoid tissue (MALT) lymphoma (POAML) is the most common subtype of indolent ocular adnexal lymphomas. Although radiotherapy (RT) is the standard of care for localized POAML, it can occ
Externí odkaz:
https://doaj.org/article/b460dddda59b42078883f9d92b82552e
Autor:
Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, Takuya Yamazaki, Sawana Ono, Hiromi Tomono, Takayuki Suyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Hiroyuki Yamaguchi, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Takashi Mizowaki, Yoshio Monzen, Takaya Ikeda, Seiji Nagashima, Yutaro Tasaki, Daisuke Nakamura, Kazutoshi Komiya, Katsumi Nakatomi, Eisuke Sasaki, Koichi Hirakawa, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 13, Iss 16, Pp 2404-2409 (2022)
Abstract Background Etoposide plus cisplatin (EP) combined with concurrent accelerated hyperfractionated thoracic radiotherapy (AHTRT) is the standard treatment strategy for unresectable limited‐disease (LD) small cell lung cancer (SCLC), which has
Externí odkaz:
https://doaj.org/article/e98bad858982435187389e1927d39f13
Autor:
Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Ayako Muramatsu, Hitoji Uchiyama, Nana Sasaki, Nobuhiko Uoshima, Mitsushige Nakao, Ryoichi Takahashi, Kazuho Shimura, Hiroto Kaneko, Miki Kiyota, Katsuya Wada, Yoshiaki Chinen, Koichi Hirakawa, Shin‐ichi Fuchida, Chihiro Shimazaki, Yayoi Matsumura‐Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda, Kyoto Clinical Hematology Study Group (KOTOSG) Investigators
Publikováno v:
Cancer Reports, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background Combinatory strategies with carfilzomib (CFZ), a second‐generation proteasome inhibitor, plus dexamethasone (DEX) with or without lenalidomide (LEN) have shown promising efficacy for patients with relapsed/refractory multiple my
Externí odkaz:
https://doaj.org/article/bdff3f7ce0164c809dccfaff7fdd38f3
Autor:
Haruya Okamoto, Yu Inoue, Akihiro Miyashita, Yuka Kawaji-Kanayama, Shotaro Chinen, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Shinsuke Mizutani, Hiroto Kaneko, Saeko Kuwahara, Shin-ichi Fuchida, Daichi Nishiyama, Koichi Hirakawa, Junya Kuroda
Publikováno v:
Blood. 140:12321-12322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7945fc3b9b8d8b030f46cd9a13c7d0ca
https://doi.org/10.1182/blood-2022-157863
https://doi.org/10.1182/blood-2022-157863
Autor:
Yu Inoue, Koichi Hirakawa, Hiroki Hayata, Daichi Nishiyama, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda
Publikováno v:
Annals of Hematology. 102:481-482
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862b132f22b4fb30b91fe8edb1fc4962
https://doi.org/10.1007/s00277-022-05038-9
https://doi.org/10.1007/s00277-022-05038-9
Autor:
Kentaro Mizuhara, Tsutomu Kobayashi, Mitsushige Nakao, Ryoichi Takahashi, Hiroto Kaneko, Kazuho Shimura, Koichi Hirakawa, Nobuhiko Uoshima, Katsuya Wada, Eri Kawata, Reiko Isa, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Akiko Yoneda, Akihide Watanabe, Chie Sotozono, Junya Kuroda
Publikováno v:
Cancer medicineREFERENCES.
Primary ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML) is the most common subtype of indolent ocular adnexal lymphomas. Although radiotherapy (RT) is the standard of care for localized POAML, it can occasionally lead to perm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a86837badf9b9b2b0dcd73801d13f7
https://pubmed.ncbi.nlm.nih.gov/36097396
https://pubmed.ncbi.nlm.nih.gov/36097396
Autor:
Ayako, Muramatsu, Tsutomu, Kobayashi, Yuka, Kawaji-Kanayama, Hitoji, Uchiyama, Nana, Sasaki, Nobuhiko, Uoshima, Mitsushige, Nakao, Ryoichi, Takahashi, Kazuho, Shimura, Hiroto, Kaneko, Miki, Kiyota, Katsuya, Wada, Yoshiaki, Chinen, Koichi, Hirakawa, Shin-Ichi, Fuchida, Chihiro, Shimazaki, Shinsuke, Mizutani, Taku, Tsukamoto, Yuji, Shimura, Masafumi, Taniwaki, Satoshi, Teramukai, Junya, Kuroda
Publikováno v:
Leukemialymphoma. 63(7)
Carfilzomib (CFZ) constitutes powerful combinatory therapy for relapsed/refractory multiple myeloma (RRMM); however, cardiovascular adverse events (CVAEs) have been shown as major treatment obstacles with the use of CFZ. Along with our multi-institut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0cf044c8c974497f303866884e9cf7
https://pubmed.ncbi.nlm.nih.gov/35147475
https://pubmed.ncbi.nlm.nih.gov/35147475
Autor:
Yuka, Kawaji-Kanayama, Ayako, Muramatsu, Nana, Sasaki, Kazuho, Shimura, Miki, Kiyota, Shinichi, Fuchida, Reiko, Isa, Takahiro, Fujino, Yayoi, Matsumura-Kimoto, Taku, Tsukamoto, Yoshiaki, Chinen, Shinsuke, Mizutani, Mitsushige, Nakao, Hiroto, Kaneko, Eri, Kawata, Koichi, Hirakawa, Ryoichi, Takahashi, Chihiro, Shimazaki, Hitoji, Uchiyama, Nobuhiko, Uoshima, Yuji, Shimura, Tsutomu, Kobayashi, Masafumi, Taniwaki, Junya, Kuroda
Publikováno v:
International journal of hematology. 115(3)
We conducted a post hoc analysis of our previous pilot observational study on the efficacy and safety of carfilzomib (CFZ)-containing therapy in 50 patients with relapsed/refractory multiple myeloma in routine practice to clarify the relationships be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eddd795059449de671b0f3a22eaf0325
https://pubmed.ncbi.nlm.nih.gov/35072907
https://pubmed.ncbi.nlm.nih.gov/35072907
Autor:
Shinsuke Mizutani, Taku Tsukamoto, Chie Sotozono, Ryoichi Takahashi, Koichi Hirakawa, Reiko Isa, Eri Kawata, Akihide Watanabe, Kentaro Mizuhara, Yuji Shimura, Akiko Yoneda, Hiroto Kaneko, Nobuhiko Uoshima, Mitsushige Nakao, Takahiro Fujino, Junya Kuroda, Tsutomu Kobayashi, Kazuho Shimura, Katsuya Wada
Background:Primary ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML) is the most common subtype of ocular adnexal lymphomas, and most patients with POAML show an indolent clinical course and achieve long-term survival. Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb8f76baa589b106f7a2a932d3849feb
https://doi.org/10.21203/rs.3.rs-677385/v1
https://doi.org/10.21203/rs.3.rs-677385/v1
Autor:
Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Ayako Muramatsu, Hitoji Uchiyama, Nana Sasaki, Nobuhiko Uoshima, Mitsushige Nakao, Ryoichi Takahashi, Kazuho Shimura, Hiroto Kaneko, Miki Kiyota, Katsuya Wada, Yoshiaki Chinen, Koichi Hirakawa, Shin‐ichi Fuchida, Chihiro Shimazaki, Yayoi Matsumura‐Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda, Kyoto Clinical Hematology Study Group (KOTOSG) Investigators
Publikováno v:
Cancer Reports, Vol 5, Iss 2, Pp n/a-n/a (2022)
Background Combinatory strategies with carfilzomib (CFZ), a second‐generation proteasome inhibitor, plus dexamethasone (DEX) with or without lenalidomide (LEN) have shown promising efficacy for patients with relapsed/refractory multiple myeloma (RR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f84d509fa2bfd30e45939e86d3a895
https://pubmed.ncbi.nlm.nih.gov/34124862
https://pubmed.ncbi.nlm.nih.gov/34124862